Coverage
-
October 23, 2015
A former CFR Pharmaceuticals SA board member has agreed to pay $13.2 million to settle U.S. Securities and Exchange Commission allegations that he traded on insider information in Abbott Laboratories' $3.3 billion takeover of CFR, according to a settlement agreement filed in New York federal court Friday.
1 other articles on this case.
View all »